U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07462325) titled 'Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary Heart Disease' on March 05.
Brief Summary: The goal of this exploratory clinical trial is to investigate the proteomic changes induced by low-dose colchicine anti-inflammatory therapy in coronary heart disease (CHD) patients, with the aim of identifying novel biomarkers and therapeutic targets.
The main questions it aims to answer are:
* Whether short-term colchicine treatment induces significant changes in the plasma proteomic profile of post-PCI CHD patients with residual inflammation.
* Which specific proteins or pathways are dynamically modulated by...